The Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold combines the trusted anti-proliferative drug, Sirolimus, with Tyrocore™, REVA’s new proprietary polymer, to make the world’s first radiopaque ...
Sirolimus Eluting Stent Only stent incorporating variable strut thickness (VST) and variable strut design (VSD) Thin 60m S-Shaped articulations in mid portion ensures flexibility ...
Diameter: 2, 2.5, 3, 3.5, 4 mm
Length: 10, 18, 24, 34, 38 mm
Sirolimus-Eluting Coronary Stent System Double-Protection Technology For Outstanding Results This is how the Accura Decent S achieves outstanding results: Carbon-Ion surface treatment technique ...
Sirolimus Eluting Coronary Stent Translumina - Prevent your Stent Thrombosis •Biodegradable Polymer DES •Long term clinical follow-up •50% reduction in definite stent ...
Translumina
Diameter: 2.5, 4, 3.5, 3, 2.75 mm
Length: 23, 18, 12, 8, 28 mm
Yinyi®Drug-loaded coronary stent system without polymer micro-blind holes Product Description Yinyi® polymer-free microblind drug-loaded (paclitaxel) coronary stent ...
Diameter: 3, 3.5, 2.5, 2.75, 2.25 mm
Length: 15, 8, 12, 17, 20 mm
... surface integrity Eluting Ridaforolimus, a high therapeutic index limus drug EluNIR First-In-Patient Implantation Dr. Alaide Chieffo, MD; Dr. Francesco Giannini, MD The first implantation of the ...
Medinol
... polylactic acid(PLA) coating as drug carrier, which will degrade completely into CO2&H2O in 6-9 month with reduced chronic inflammatory reactions -Effective reduction of the risk of in-stent ST/VLST -Targeted ...
... coating as drug carrier, which will degrade completely into CO2&H2O in 6-9 month, with reduced chronic inflammatory reactions - Lower rates of MACE with safety proved 6 months DAPT - Significantly lower rate of ...
Please specify:
Help us improve:
remaining